Literature DB >> 20872947

Prognostic value of the sixth edition of the UICC's TNM classification and stage grouping for oral cancer.

Matthias Kreppel1, Hans Theodor Eich, Alexander Kübler, Joachim E Zöller, Martin Scheer.   

Abstract

BACKGROUND: Carcinoma of the oral cavity is classified according to the TNM staging system of the UICC. The staging system is under continuous revision. The aim of our study was to assess the prognostic value of the UICC sixth edition for oral cancer, which was established in 2003.
METHODS: Three-hundred treatment-naive patients with oral squamous cell carcinoma (OSCC) of stages I-IVb were reviewed retrospectively. Patients with stage-I disease were treated solely surgically, and patients with stage II-IVb received a multimodal treatment. Overall survival was plotted by Kaplan-Meier analysis. Prognostic factors were identified through univariate and multivariate analysis.
RESULTS: Univariate analysis showed a significant impact of T stage (P = 0.009), N stage (P < 0.001), and UICC stage (P < 0.001) on overall survival. However, no statistical differences were observed between stages T4a and T4b (P = 0.176) and UICC stages IVa and IVb (P = 0.306).
CONCLUSIONS: T stage, N stage, and UICC stage grouping are good predictors of overall survival in patients with OSCC. Neither the division of stage T4 into T4a and T4b in the sixth edition nor the split of stage IV into IVa and IVb showed significant differences in overall survival between the subgroups. J. Surg. Oncol. 2010;102:443-449.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20872947     DOI: 10.1002/jso.21547

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  24 in total

1.  The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL.

Authors:  Francesco Carinci; Lorenzo Monasta; Corrado Rubini; Daniela Stramazzotti; Annalisa Palmieri; Elisabetta Melloni; Alex Knowles; Luca Ronfani; Giorgio Zauli; Paola Secchiero
Journal:  Invest New Drugs       Date:  2010-11-18       Impact factor: 3.850

2.  Primary radical ablative surgery and fibula free-flap reconstruction for T4 oral cavity squamous cell carcinoma with mandibular invasion: oncologic and functional results and their predictive factors.

Authors:  Olivier Camuzard; Olivier Dassonville; Marc Ettaiche; Emmanuel Chamorey; Gilles Poissonnet; Riadh Berguiga; Axel Leysalle; Karen Benezery; Frédéric Peyrade; Esma Saada; Raphael Hechema; Anne Sudaka; Juliette Haudebourg; François Demard; José Santini; Alexandre Bozec
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-07-20       Impact factor: 2.503

3.  Combined-modality treatment in advanced oral squamous cell carcinoma: Primary surgery followed by adjuvant concomitant radiochemotherapy.

Authors:  Matthias Kreppel; Uta Drebber; Hans-Theodor Eich; Timo Dreiseidler; Joachim E Zöller; Rolf-Peter Müller; Martin Scheer
Journal:  Strahlenther Onkol       Date:  2011-03-14       Impact factor: 3.621

4.  Standardized pretreatment inflammatory laboratory markers and calculated ratios in patients with oral squamous cell carcinoma.

Authors:  Martin Grimm; Johan Rieth; Sebastian Hoefert; Michael Krimmel; Sven Rieth; Peter Teriete; Susanne Kluba; Thorsten Biegner; Adelheid Munz; Siegmar Reinert
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-29       Impact factor: 2.503

5.  Delayed diagnosis of oral squamous cell carcinoma following dental treatment.

Authors:  T Singh; M Schenberg
Journal:  Ann R Coll Surg Engl       Date:  2013-07       Impact factor: 1.891

6.  Clinical relevance of a new pre-treatment laboratory prognostic index in patients with oral squamous cell carcinoma.

Authors:  M Grimm; M Lazariotou
Journal:  Med Oncol       Date:  2011-08-19       Impact factor: 3.064

7.  The effect of preventive oral care on treatment outcomes of a cohort of oral cancer patients.

Authors:  Marilia Oliveira Morais; Marcela Ramos Abrahão Elias; Cláudio Rodrigues Leles; Juliana Castro Dourado Pinezi; Elismauro Francisco Mendonça
Journal:  Support Care Cancer       Date:  2015-09-26       Impact factor: 3.603

8.  Outcome and fewer indications for adjuvant therapy for patients with oral squamous cell carcinomas under standardized tumor board conditions.

Authors:  Alexander Gröbe; Lena Rybak; Gerhard Schön; Ralf Smeets; Silke Tribius; Philippe Schafhausen; Till S Clauditz; Henning Hanken; Max Heiland
Journal:  J Cancer Res Clin Oncol       Date:  2015-10-27       Impact factor: 4.553

9.  Protumoral roles of melanoma inhibitory activity 2 in oral squamous cell carcinoma.

Authors:  M Kurihara; T Kirita; T Sasahira; H Ohmori; S Matsushima; K Yamamoto; A K Bosserhoff; H Kuniyasu
Journal:  Br J Cancer       Date:  2013-03-19       Impact factor: 7.640

10.  Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer.

Authors:  Claus Wittekindt; Steffen Wagner; Christina Sabine Mayer; Jens Peter Klussmann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.